​

Hims & Hers Health (HIMS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HIMS Stock Forecast

Hims & Hers Health (HIMS) stock forecast, based on 17 Wall Street analysts, predicts a 12-month average price target of $42.83, with a high of $59.00 and a low of $32.00. This represents a 13.40% increase from the last price of $37.77.

$5 $16 $27 $38 $49 $60 High: $59 Avg: $42.83 Low: $32 Last Closed Price: $37.77

HIMS Stock Rating

Hims & Hers Health stock's rating consensus is Hold, based on 17 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (29.41%), 10 Hold (58.82%), 2 Sell (11.76%), and 0 Strong Sell (0.00%).

Hold
Total 17 0 2 10 5 Strong Sell Sell Hold Buy Strong Buy

HIMS Price Target Upside V Benchmarks

TypeNameUpside
StockHims & Hers Health13.40%
SectorHealthcare Stocks 15.45%

Price Target Trends

1M3M12M
# Anlaysts2711
Avg Price Target$44.50$43.29$46.45
Last Closing Price$37.77$37.77$37.77
Upside/Downside17.82%14.61%22.98%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25-281213
Nov, 25-382114
Oct, 25-372113
Sep, 25-371112
Aug, 25-371112
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 08, 2025Barclays$48.00$39.1222.70%27.08%
Dec 04, 2025Michael ChernyLeerink Partners$41.00$40.231.91%8.55%
Nov 12, 2025Craig HettenbachMorgan Stanley$40.00$39.750.63%5.90%
Nov 04, 2025Seaport Global$59.00$44.7131.96%56.21%
Nov 04, 2025Jailendra SinghTruist Financial$37.00$44.73-17.28%-2.04%
Nov 04, 2025UBS$32.00$44.39-27.91%-15.28%
Nov 04, 2025Michael ChernyLeerink Partners$46.00$44.393.63%21.79%
Jun 24, 2025Jailendra SinghTruist Financial$45.00$42.954.77%19.14%
Jun 23, 2025UBS$30.00$41.98-28.54%-20.57%
Jun 04, 2025Ryan MacdonaldNeedham$65.00$53.6121.25%72.09%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 08, 2025BarclaysOverweightinitialise
Dec 04, 2025Leerink PartnersOutperformOutperformhold
Nov 04, 2025Leerink PartnersMarket PerformMarket Performhold
Nov 04, 2025KeyBancSector WeightSector Weighthold
Nov 04, 2025NeedhamHoldHoldhold
Nov 04, 2025UBSUnderperformUnderperformhold
Oct 28, 2025Cowen & Co.HoldHoldhold
Oct 21, 2025KeyBancSector Weightinitialise
Jun 28, 2025ScotiabankSector Performdowngrade
Jun 23, 2025CitigroupSellSellhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.51$-0.58$-0.32$-0.11$0.58----
Avg Forecast$-0.28$-0.36$-0.32$-0.13$0.54$0.52$0.72$0.84$0.56
High Forecast$-0.26$-0.34$-0.28$-0.11$0.58$0.70$0.98$1.19$0.62
Low Forecast$-0.30$-0.40$-0.35$-0.15$0.50$0.28$0.39$0.45$0.46
Surprise %82.14%61.11%--15.38%7.41%----

Revenue Forecast

$0 $700M $1B $2B $3B $4B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$148.76M$271.88M$526.92M$872.00M$1.48B----
Avg Forecast$144.28M$264.20M$520.90M$871.89M$1.46B$2.04B$2.35B$2.74B$2.83B
High Forecast$154.07M$282.12M$557.08M$872.88M$1.47B$2.21B$2.36B$2.78B$3.06B
Low Forecast$136.46M$249.87M$469.87M$870.58M$1.45B$1.78B$2.34B$2.70B$2.46B
Surprise %3.10%2.90%1.15%0.01%1.12%----

Net Income Forecast

$-150M $-70M $10M $90M $170M $250M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-18.11M$-107.66M$-65.68M$-23.55M$126.04M----
Avg Forecast$-57.85M$-108.55M$-67.50M$-23.55M$113.41M$120.85M$172.21M$238.96M$117.23M
High Forecast$-53.77M$-86.84M$-58.90M$-18.84M$121.66M$146.94M$204.73M$248.44M$129.47M
Low Forecast$-62.95M$-130.26M$-73.59M$-28.26M$105.16M$58.78M$81.25M$94.80M$97.17M
Surprise %-68.69%-0.82%-2.69%-11.14%----

HIMS Forecast FAQ

Is Hims & Hers Health stock a buy?

Hims & Hers Health stock has a consensus rating of Hold, based on 17 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 10 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Hims & Hers Health is a neutral investment for most analysts.

What is Hims & Hers Health's price target?

Hims & Hers Health's price target, set by 17 Wall Street analysts, averages $42.83 over the next 12 months. The price target range spans from $32 at the low end to $59 at the high end, suggesting a potential 13.40% change from the previous closing price of $37.77.

How does Hims & Hers Health stock forecast compare to its benchmarks?

Hims & Hers Health's stock forecast shows a 13.40% upside, underperforming the average forecast for the healthcare stocks sector (15.45%).

What is the breakdown of analyst ratings for Hims & Hers Health over the past three months?

  • December 2025: 0% Strong Buy, 15.38% Buy, 61.54% Hold, 7.69% Sell, 15.38% Strong Sell.
  • November 2025: 0% Strong Buy, 21.43% Buy, 57.14% Hold, 14.29% Sell, 7.14% Strong Sell.
  • October 2025: 0% Strong Buy, 23.08% Buy, 53.85% Hold, 15.38% Sell, 7.69% Strong Sell.

What is Hims & Hers Health’s EPS forecast?

Hims & Hers Health's average annual EPS forecast for its fiscal year ending in December 2025 is $0.52, marking a -10.34% decrease from the reported $0.58 in 2024. Estimates for the following years are $0.72 in 2026, $0.84 in 2027, and $0.56 in 2028.

What is Hims & Hers Health’s revenue forecast?

Hims & Hers Health's average annual revenue forecast for its fiscal year ending in December 2025 is $2.04B, reflecting a 38.45% increase from the reported $1.48B in 2024. The forecast for 2026 is $2.35B, followed by $2.74B for 2027, and $2.83B for 2028.

What is Hims & Hers Health’s net income forecast?

Hims & Hers Health's net income forecast for the fiscal year ending in December 2025 stands at $120.85M, representing a -4.12% decrease from the reported $126.04M in 2024. Projections indicate $172.21M in 2026, $238.96M in 2027, and $117.23M in 2028.